Skip to content
StockMarketAgent
Financials / Banks - RegionalUpdated 2026-05-10 22:07 UTC

BIT/BMED stock hub

BIT/BMED has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BIT/BMEDis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
14.3B
Borsa Italiana
Market data

Live price

Current market quote for this ticker.

Current price
BIT/BMED
In the news

Latest news · BIT/BMED

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5
P25 9.4P50 10.9P75 13.5
Trailing P/E11.6
P25 8.6P50 10.4P75 13.7
ROE27.8
P25 7P50 13.2P75 18
ROICn/a
P25 -0.5P50 4.9P75 10
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BIT/BMED market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
EUR
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Italy
Country code
IT
Employees
4,042
Employees Change
217%
Employees Change Percent
5.67
Exchange
Borsa Italiana
Financial currency
EUR
First seen
2026-05-10
Industry
Banks - Regional
Isin
IT0004776628
Last refreshed
2026-05-10
Market cap
EUR 14.3B
Price
EUR 19.3
Price currency
EUR
Rev Per Employee
603,973.78x
Sector
Financials
Sic
6200
Symbol
bit/BMED
Website
https://www.bancamediolanum.it

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
8.91%
Forward P/E
13.5x
P/B ratio
2.99x
P/E ratio
11.61x
P/S ratio
5.84x
PE Ratio10 Y
11.05x
PE Ratio3 Y
9.26x
PE Ratio5 Y
9.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
Gross Profit
EUR 2.4B
Net Income
EUR 1.3B
Net Income Growth
11.24%
Net Income Growth Q
13.51%
Net Income Growth Quarters
13%
Net Income Growth Years
3%
Net Income Growth3 Y
30.58%
Net Income Growth5 Y
20.72%
Pretax Margin
60.59%
Profit Margin
52.06%
Profit Per Employee
EUR 314,401
Profitable Years
22
ROA
1.41
Roa5y
1.12
ROE
27.82
Roe5y
25.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

19
MetricValue
Cagr10y
17.92%
Cagr1y
50.09%
Cagr3y
43.89%
Cagr5y
30.21%
Div CAGR10
15.34%
Div CAGR3
35.72%
Div CAGR5
115.86%
EPS Growth
12.52
EPS Growth Q
14.61
EPS Growth Quarters
13
EPS Growth Years
3
EPS Growth3 Y
30.85
EPS Growth5 Y
20.67
Revenue Growth
2.87x
Revenue Growth Q
6.01x
Revenue Growth Quarters
2x
Revenue Growth Years
3x
Revenue Growth3 Y
18.47x
Revenue Growth5 Y
13.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

11
MetricValue
Assets
EUR 94.3B
Cash
EUR 1.7B
Debt
EUR 1.9B
Equity
EUR 4.8B
Liabilities
EUR 89.5B
Net Cash
EUR -193M
Net Cash By Market Cap
EUR -1.35
Net Debt Equity
EUR 0.04
Tangible Book Value
EUR 4.6B
Tangible Book Value Per Share
EUR 6.16
WACC
7.4

Liquidity

Current-asset coverage and working-capital efficiency metrics.

1
MetricValue
Working Capital
EUR -54.3B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

9
MetricValue
Buyback Yield
1.14%
Dividend Growth
25%
Dividend Growth Years
2%
Dividend per share
EUR 1.3
Dividend Years
6
Dividend Yield
6.74%
Ex Div Date
2026-04-20
Last Dividend
EUR 0.65
Payout Frequency
Semi-Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
419.82%
1Y total return
50.05%
200-day SMA
17.86
3Y total return
197.97%
50-day SMA
17.89
50-day SMA vs 200-day SMA
50over200
5Y total return
274.17%
All Time High
20.68
All Time High Change
-6.67%
All Time High Date
2026-02-03
All Time Low
4.02
All Time Low Change
379.62%
All Time Low Date
2020-03-19
ATR
0.46
Beta
0.75
Beta1y
0.87
Beta2y
0.96
Ch YTD
-0.87
High
19.43
High52
20.68
High52 Date
2026-02-03
High52ch
-6.67%
Low
18.97
Low52
13.72
Low52 Date
2025-05-08
Low52ch
41.91%
Ma50ch
7.86%
Price vs 200-day SMA
8.09%
RSI
62.29
RSI Monthly
70.12
RSI Weekly
57.73
Sharpe ratio
1.6x
Sortino ratio
2.61
Total Return
7.87%
Tr YTD
2.53
Tr1m
12.52%
Tr1w
5.72%
Tr3m
0.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 1.5B
Operating margin
62.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
244,915,588%
Shares Insiders
6.9%
Shares Institutions
9.82%
Shares Out
739,307,887
Shares Qo Q
-0.69%
Shares Yo Y
-1.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

46
MetricValue
Average Volume
1,469,736.25x
Bv Per Share
6.46
Ch10y
169.9
Ch1m
8.79
Ch1w
5.72
Ch1y
40.36
Ch3m
-2.38
Ch3y
138.2
Ch5y
140.8
Ch6m
7.04
Change
0.29%
Change From Open
0.52
Close
19.25
Days Gap
-0.26
Dollar Volume
20,172,051.2
Earnings Date
2026-05-07
EPS
EUR 1.72
F Score
2
Fiscal Year End
December
Founded
1,982
Goodwill
126,000,000
Graham Number
15.80506
Graham Upside
-18.11
Income Tax
EUR 208.3M
Is Primary Listing
1
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Lynch Fair Value
EUR 35.62
Lynch Upside
84.58
Ma150
18.27
Ma150ch
5.66%
Ma20
18.77
Ma20ch
2.84%
Next Earnings Date
2026-07-30
Open
19.2
Payment Date
2026-04-22
Position In Range
71.74
Ppne
222,000,000
Price Date
2026-05-08
Ptbv Ratio
3.13
Relative Volume
0.73x
Revenue
2,441,262,000x
Tax By Revenue
8.53x
Tax Rate
14.09%
Tr6m
14.43%
Volume
1,045,184
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

BIT/BMED dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.7%
$1.30 annual per share
Payout ratio
n/a
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+115.9%
2 consecutive years of growth
Total shareholder yield
+7.9%
Next ex-dividend date: 2026-04-20
Performance

BIT/BMED stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+50.0%
S&P 500 1Y: n/a
3Y total return
+198.0%
S&P 500 3Y: n/a
5Y total return
+274.2%
S&P 500 5Y: n/a
10Y total return
+419.8%
S&P 500 10Y: n/a
Ownership

Who owns BIT/BMED?

Insider, institutional, and short-interest positioning.

Institutional ownership
+9.8%
Share of float held by funds and institutions
Insider ownership
+6.9%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.1%
Negative means the company is buying back shares.
Technical

BIT/BMED momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
62.3
Neutral momentum band
Price vs 200-day MA
+8.1%
50/200-day relationship not available
Beta (5Y)
0.75
Less volatile than the market
Sharpe ratio
1.60
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BIT/BMED

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bit/BMED stock rating?

bit/BMED is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bit/BMED analysis?

The full report lives at /stocks/bit/BMED/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bit/BMED?

The latest report frames bit/BMED around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bit/BMED page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bit/BMED stock profile: metrics, valuation and analysis | StockMarketAgent.AI